Company: CRLBF
Filing Date: 2025-09-18
Form Type: SC TO-I/A
Source: 0001832928-25-000026
Chunk: 1

Company: Cresco Labs Inc.
Filing Date: 2025-09-18
Form: SC TO-I/A
Chunk 1
---
 TO ”), by Cresco Labs Inc., a corporation organized under the laws of the Province of British Columbia (the “ Company ”), relating to the offer by the Company to certain optionholders to exchange (the “ Exchange Offer ”) certain outstanding options to purchase the Company’s subordinate voting shares for new restricted stock units (the “ New Awards ”).

This Amendment is being filed in accordance with Rule 13e-4(c)(4) under the Securities Exchange Act of 1934, as amended, to report the final results of the Exchange Offer. Except as specifically set forth herein, this Amendment does not modify any of the information previously reported on the Schedule TO. You should read this Amendment together with the Schedule TO. All capitalized terms used herein have the same meanings as given in the Schedule TO.

## ITEM 4. Terms of the Transaction.
Item 4(a) of the Schedule TO is hereby amended and supplemented by adding the following information:

(a) Material Terms .

Shareholder Approval of the Exchange Offer was obtained at the Company’s annual general and special meeting held on September 16, 2025. The Exchange Offer expired at 11:59 p.m., Eastern Time, on Wednesday, September 17, 2025. Pursuant to the Exchange Offer, 14 Eligible Participants elected to exchange, and the Company accepted for cancellation, Eligible Options to purchase an aggregate of 8,865,902 subordinate voting shares, representing approximately 99% of the total subordinate voting shares underlying Eligible Options. On September 17, 2025, immediately following the expiration of the Exchange Offer, the Company granted 8,865,902 RSUs, pursuant and subject to the terms of the Exchange Offer and the 2018 Incentive Plan. The New Awards vest ratably over three years as described in the Exchange Offer.

## ITEM 12. Exhibits.
| Calculation of Filing Fee Tables |

### SIGNATURE
After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

| Cresco Labs Inc. |     |                      |     |                         |
| By:              |     | /s/ Charles Bachtell |     |                         |
|                  |     | Name:                |     | Charles Bachtell        |
|                  |     | Title:               |     | Chief Executive Officer |

Date: September 18, 2025